Breaking News, Financial News

Financial Report: Charles River 1Q

Preclinical Services revenue was $140.0 million (-17%) due primarily to slower market demand.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Charles River 1Q 1Q Revenues: $301.5 million (-11%) 1Q Earnings: $25.4 million (-42%) Comments: Preclinical Services revenue was $140.0 million (-17%) due primarily to slower market demand. Sales for the Research Models and Services segment were $161.5 million in the quarter (-4%)....

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters